Literature DB >> 12086909

Resected adenocarcinoma of the pancreas--616 patients: results, outcomes, and prognostic indicators.

J Forgensen.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 12086909     DOI: 10.1016/s1091-255x(01)80113-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  1 in total

1.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

  1 in total
  3 in total

Review 1.  [Survival, mortality and quality of life after pylorus-preserving or classical Whipple operation. A systematic review with meta-analysis].

Authors:  C Fitzmaurice; C M Seiler; M W Büchler; M K Diener
Journal:  Chirurg       Date:  2010-05       Impact factor: 0.955

2.  Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.

Authors:  Xing Huang; Gang Zhang; Tianyu Tang; Tingbo Liang
Journal:  Mol Cancer       Date:  2021-03-01       Impact factor: 27.401

3.  Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer.

Authors:  Carmine Carbone; Geny Piro; Antonio Agostini; Pietro Delfino; Francesco De Sanctis; Vincenzo Nasca; Francesco Spallotta; Claudio Sette; Maurizio Martini; Stefano Ugel; Vincenzo Corbo; Paola Cappello; Emilio Bria; Aldo Scarpa; Giampaolo Tortora
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 12.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.